Anti-Inflammatory Drugs as Antivenom?

Compounds typically used to calm the immune system can prevent death from scorpion venom in mice, researchers report.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, CLINTON & CHARLES ROBERTSONAntidotes to scorpion venom may have been lurking under our noses for quite a while. Researchers in Brazil have found that they could keep mice stung by scorpions from succumbing to the toxic effects of the venom by administering the anti-inflammatory drugs indomethacin or celecoxib. The team, led by investigators at the University of São Paulo, published its results yesterday (February 23) in Nature Communications.

The team administered either indomethacin or celecoxib to mice dosed with scorpion venom, finding that both anti-inflammatory drugs protected against death. If the drugs have the same effects in humans, they could become regular fixtures of first-aid kits, obviating the need for expensive, more-volatile, and less-widely applicable antibody-based antivenoms. “The possibility for a generic treatment is exciting,” Yale University immunologist Noah Palm, who was not involved in the work, told Chemical & Engineering News.

The anti-inflammatory drugs apparently blocked prostaglandin E2, a lipid signaling molecule that causes lung edema and inflammation in animals stung by scorpions. This saved the mice from the deadly effects of the toxin. Lucia Faccioli of the University of São Paulo told Chemical & Engineering News that her team next plans ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo